+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Spinal Cord Stimulation Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968591
  • Report
  • July 2021
  • Region: Global
  • 185 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Spinal Cord Stimulation Market will Grow to USD 2,719.88 Million by 2026, at a CAGR of 9.30%

FEATURED COMPANIES

  • Abbott Laboratories
  • Gimer Medical
  • LivaNova PLC
  • Neuronano
  • NeuroSigma, Inc.
  • Saluda Medical Pvt ltd
  • MORE
The Global Spinal Cord Stimulation Market size was estimated at USD 1,595.09 Million in 2020 and expected to reach USD 1,738.07 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.30% to reach USD 2,719.88 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Spinal Cord Stimulation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Spinal Cord Stimulation Market was studied across Non-rechargeable and Rechargeable.
  • Based on Application, the Spinal Cord Stimulation Market was studied across Complex Regional Pain Syndrome, Failed Back Surgery Syndrome, and Ischemic Limb Pain.
  • Based on End User, the Spinal Cord Stimulation Market was studied across Ambulatory Surgical Units, Clinics, and Hospitals.
  • Based on Region, the Spinal Cord Stimulation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spinal Cord Stimulation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spinal Cord Stimulation Market, including Abbott Laboratories, Autonomic Technologies Inc., Beijing PINS Medical Co., Ltd, BioControl Medical (B.C.M) Ltd., Bioinduction, Bluewind Medical, Boston Scientific Corporation, Cirtec Medical Corporation, Gimer Medical, Greatbatch, Inc., GTX Medical, Helius Medical Technologies, Integer Holdings Corporation, LivaNova PLC, Medtronic PLC, Microtransponder, Neuronano, Neuronetics Inc., Neuropace Inc., NeuroSigma, Inc., Nevro Corp., Nuvectra, Saluda Medical Pvt ltd, Soterix Medical, Spinal Modulation, Stimwave LLC, and Synapse Biomedical, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Spinal Cord Stimulation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Cord Stimulation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Cord Stimulation Market?
4. What is the competitive strategic window for opportunities in the Global Spinal Cord Stimulation Market?
5. What are the technology trends and regulatory frameworks in the Global Spinal Cord Stimulation Market?
6. What is the market share of the leading vendors in the Global Spinal Cord Stimulation Market?
7. What modes and strategic moves are considered suitable for entering the Global Spinal Cord Stimulation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Gimer Medical
  • LivaNova PLC
  • Neuronano
  • NeuroSigma, Inc.
  • Saluda Medical Pvt ltd
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. End User Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of failed back syndrome
5.1.1.2. Favorable medical reimbursements
5.1.1.3. Growth in degenerative disk disease (DDD) and multiple back surgeries
5.1.2. Restraints
5.1.2.1. High cost for implementation
5.1.3. Opportunities
5.1.3.1. R&D for advancement in product functionality
5.1.3.2. Inclination towards non-invasive treatments and surgeries
5.1.4. Challenges
5.1.4.1. Product recalls
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Spinal Cord Stimulation Market, by Product
6.1. Introduction
6.2. Non-rechargeable
6.3. Rechargeable

7. Spinal Cord Stimulation Market, by Application
7.1. Introduction
7.2. Complex Regional Pain Syndrome
7.3. Failed Back Surgery Syndrome
7.4. Ischemic Limb Pain

8. Spinal Cord Stimulation Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Units
8.3. Clinics
8.4. Hospitals

9. Americas Spinal Cord Stimulation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Spinal Cord Stimulation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Spinal Cord Stimulation Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Autonomic Technologies Inc.
13.3. Beijing PINS Medical Co., Ltd
13.4. BioControl Medical (B.C.M) Ltd.
13.5. Bioinduction
13.6. Bluewind Medical
13.7. Boston Scientific Corporation
13.8. Cirtec Medical Corporation
13.9. Gimer Medical
13.10. Greatbatch, Inc.
13.11. GTX Medical
13.12. Helius Medical Technologies
13.13. Integer Holdings Corporation
13.14. LivaNova PLC
13.15. Medtronic PLC
13.16. Microtransponder
13.17. Neuronano
13.18. Neuronetics Inc.
13.19. Neuropace Inc.
13.20. NeuroSigma, Inc.
13.21. Nevro Corp.
13.22. Nuvectra
13.23. Saluda Medical Pvt ltd
13.24. Soterix Medical
13.25. Spinal Modulation
13.26. Stimwave LLC
13.27. Synapse Biomedical, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 4. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL SPINAL CORD STIMULATION MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL SPINAL CORD STIMULATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 17. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2026
FIGURE 19. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 26. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END USER, 2026
FIGURE 28. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. CANADA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. MEXICO SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. CHINA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. INDIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. JAPAN SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. THAILAND SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. FRANCE SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. GERMANY SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. ITALY SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. QATAR SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. SPAIN SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. GLOBAL SPINAL CORD STIMULATION MARKET: FPNV POSITIONING MATRIX
FIGURE 64. GLOBAL SPINAL CORD STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPINAL CORD STIMULATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL SPINAL CORD STIMULATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY NON-RECHARGEABLE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY RECHARGEABLE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY FAILED BACK SURGERY SYNDROME, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY ISCHEMIC LIMB PAIN, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY AMBULATORY SURGICAL UNITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL SPINAL CORD STIMULATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 16. ARGENTINA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 17. BRAZIL SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 18. CANADA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 19. MEXICO SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 20. UNITED STATES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 21. ASIA-PACIFIC SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. AUSTRALIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. CHINA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. INDIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. INDONESIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. JAPAN SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. MALAYSIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. PHILIPPINES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. SINGAPORE SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. SOUTH KOREA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. THAILAND SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. FRANCE SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. GERMANY SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. ITALY SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. NETHERLANDS SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. QATAR SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. RUSSIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SAUDI ARABIA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. SOUTH AFRICA SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SPAIN SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. UNITED ARAB EMIRATES SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. UNITED KINGDOM SPINAL CORD STIMULATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. GLOBAL SPINAL CORD STIMULATION MARKET: SCORES
TABLE 45. GLOBAL SPINAL CORD STIMULATION MARKET: BUSINESS STRATEGY
TABLE 46. GLOBAL SPINAL CORD STIMULATION MARKET: PRODUCT SATISFACTION
TABLE 47. GLOBAL SPINAL CORD STIMULATION MARKET: RANKING
TABLE 48. GLOBAL SPINAL CORD STIMULATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 49. GLOBAL SPINAL CORD STIMULATION MARKET: MERGER & ACQUISITION
TABLE 50. GLOBAL SPINAL CORD STIMULATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. GLOBAL SPINAL CORD STIMULATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. GLOBAL SPINAL CORD STIMULATION MARKET: INVESTMENT & FUNDING
TABLE 53. GLOBAL SPINAL CORD STIMULATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 54. GLOBAL SPINAL CORD STIMULATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Autonomic Technologies Inc.
  • Beijing PINS Medical Co., Ltd
  • BioControl Medical (B.C.M) Ltd.
  • Bioinduction
  • Bluewind Medical
  • Boston Scientific Corporation
  • Cirtec Medical Corporation
  • Gimer Medical
  • Greatbatch, Inc.
  • GTX Medical
  • Helius Medical Technologies
  • Integer Holdings Corporation
  • LivaNova PLC
  • Medtronic PLC
  • Microtransponder
  • Neuronano
  • Neuronetics Inc.
  • Neuropace Inc.
  • NeuroSigma, Inc.
  • Nevro Corp.
  • Nuvectra
  • Saluda Medical Pvt ltd
  • Soterix Medical
  • Spinal Modulation
  • Stimwave LLC
  • Synapse Biomedical, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll